Sedative and Analgesic Effects of Propofol-Fentanyl Versus Propofol-Ketamine During Endoscopic Retrograde Cholangiopancreatography: A Double-Blind Randomized Clinical Trial
Overview
Affiliations
Background: Endoscopic retrograde cholangiopancreatography (ERCP) is a painful procedure that requires analgesia and sedation.
Objectives: In this study, we compared the analgesic and sedative effects of propofol-ketamine versus propofol-fentanyl in patients undergoing ERCP.
Methods: In this clinical trial, 72 patients, aged 30 - 70 years old, who were candidates for ERCP were randomly divided into two groups. Before the start of ERCP, both groups received midazolam 0.5 - 1 mg. The intervention group (PK) received ketamine 0.5 mg/kg, and the control group (PF) received fentanyl 50 - 100 micrograms. All patients received propofol 0.5 mg/kg in a loading dose followed by 75 mcg/kg/minute in an infusion. The patients, the anesthesiologist, and the endoscopist were unaware of the medication regimen. Sedation and analgesia quality (based on a VAS), blood pressure, respiratory rate, heart rate, arterial oxygen saturation, recovery time (based on Aldrete scores), and endoscopist and patient satisfation were recorded.
Results: The sedative effects were equal in the two groups (P > 0.05), but the analgesic effects were higher in the PF group than in the PK group (P < 0.05). The PK group had higher blood pressure levels in the eighth minute. Respiratory rate, heart rate, and arterial oxygen saturation showed no significant differences between the groups (P > 0.05). Endoscopist satisfaction, patient satisfaction, and recovery time showed no significant differences between the two groups (P > 0.05).
Conclusions: The results showed that the sedative effect of propofol-ketamine was equal to the propofol-fentanyl combination during ERCP. To prevent respiratory and hemodynamic complications during ERCP, the propofol-ketamine combination should be used in patients with underlying disease.
Liu Y, Xiao J, Chen T, Shi D, Qiao Y, Liao X Dig Dis. 2024; 43(1):84-95.
PMID: 39536718 PMC: 11817864. DOI: 10.1159/000542380.
Babu T, Anil Kumar M, Anup N, Shetty S J Pharm Bioallied Sci. 2024; 16(Suppl 1):S399-S402.
PMID: 38595396 PMC: 11001155. DOI: 10.4103/jpbs.jpbs_617_23.
Nie J, Chen W, Jia Y, Zhang Y, Wang H BMC Pulm Med. 2023; 23(1):254.
PMID: 37430293 PMC: 10334652. DOI: 10.1186/s12890-023-02517-1.
Zheng Y, Xu Y, Huang B, Mai Y, Zhang Y, Zhang Z Front Pharmacol. 2022; 13:956392.
PMID: 36204220 PMC: 9530901. DOI: 10.3389/fphar.2022.956392.
Hormati A, Aminnejad R, Saeidi M, Ghadir M, Mohammadbeigi A, Shafiee H Anesth Pain Med. 2019; 9(4):e95796.
PMID: 31754612 PMC: 6825367. DOI: 10.5812/aapm.95796.